A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.

• Status: ACTIVE_NOT_RECRUITING
• Trial end date: 2025-10-31

Summary

The main aim of this study is to assess the effects of AZD0780 when added on top of ezetimibe or ezetimibe and rosuvastatin or ezetimibe and bempedoic acid.

• Phase: PHASE1

Details

• Lead Sponsor: AstraZeneca
• Treatments: 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid; Ezetimibe; Rosuvastatin Calcium